MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Evoke Pharma Long Term Debt Current 2011-2026 | EVOK
Annual Long Term Debt Current Evoke Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.4 K | 129 K | 12.4 K | 142 K | 139 K | - | - | - | 146 K | 150 K | 1.44 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 M | 12.4 K | 272 K |
Long Term Debt Current of other stocks in the Drug manufacturers industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
5.36 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
366 K | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
1.38 M | - | - | $ 50.1 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
357 K | $ 4.16 | -2.8 % | $ 58.5 M | USA |
 |
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | USA |
 |
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
582 K | - | - | $ 2.06 B |  France |
 |
Calliditas Therapeutics AB (publ)
CALT
|
3.91 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M |  Canada |
 |
Bausch Health Companies
BHC
|
61 M | $ 5.58 | -1.76 % | $ 2.04 B | Canada |
 |
Canopy Growth Corporation
CGC
|
7.46 M | $ 1.12 | -2.34 % | $ 120 M | Canada |
 |
Jupiter Wellness
JUPW
|
23.5 K | - | - | $ 33.6 M | USA |
 |
Harrow Health
HROW
|
887 K | $ 40.19 | -0.72 % | $ 1.48 B | USA |
 |
Organogenesis Holdings
ORGO
|
4.27 M | $ 2.34 | -2.5 % | $ 308 M | USA |
 |
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | USA |
 |
Pacira BioSciences
PCRX
|
8.89 M | $ 25.29 | -0.47 % | $ 1.17 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
58 K | $ 1.04 | - | $ 1.29 M | USA |
 |
OrganiGram Holdings
OGI
|
1.03 M | $ 1.37 | -2.5 % | $ 402 M | Canada |
 |
Tilray
TLRY
|
2.47 M | $ 6.26 | -4.71 % | $ 3.87 B | Canada |
 |
Veru
VERU
|
1.07 M | $ 2.3 | 0.44 % | $ 310 M | USA |
 |
Evolus
EOLS
|
2.53 M | $ 5.3 | 0.57 % | $ 342 M | USA |
 |
Sundial Growers
SNDL
|
35.5 M | $ 1.36 | -8.16 % | $ 3.37 M | Canada |
 |
Viatris
VTRS
|
80.6 M | $ 14.85 | 0.17 % | $ 17.8 B | USA |
 |
Emergent BioSolutions
EBS
|
3.5 M | $ 8.11 | -1.4 % | $ 415 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.05 M | - | - | $ 193 M | Canada |
 |
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | USA |
 |
ProPhase Labs
PRPH
|
301 K | - | - | $ 5.07 M | USA |
 |
cbdMD
YCBD
|
98.7 K | $ 0.82 | -10.89 % | $ 3.54 M | USA |
 |
Assertio Holdings
ASRT
|
240 K | $ 18.07 | 0.17 % | $ 116 M | USA |
 |
Solid Biosciences
SLDB
|
2.1 M | $ 7.38 | -1.01 % | $ 646 M | USA |
 |
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
911 K | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
483 K | $ 0.97 | -1.35 % | $ 48.4 M | USA |
 |
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | USA |
 |
Aurora Cannabis
ACB
|
5.38 M | $ 3.34 | -2.34 % | $ 86.3 M | Canada |
 |
Zomedica Corp.
ZOM
|
717 K | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
215 K | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
1.16 M | $ 0.88 | -1.27 % | $ 31.7 M | USA |
 |
Tricida
TCDA
|
2.74 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
71.6 K | $ 0.56 | -7.59 % | $ 2.4 M |  China |
 |
TherapeuticsMD
TXMD
|
975 K | $ 2.1 | - | $ 24.3 M | USA |